Ad Astra Diagnostics’ Hematology Analyzer Gets 510(k) Clearance
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read MorePosted by Andy Lundin | Dec 7, 2023 | Hematology Instrumentation |
The hematology analyzer provides patient-side results to screen for conditions including infection, leukemia, and other blood-related cancers.
Read MorePosted by Andy Lundin | Dec 4, 2023 | Lab Automation, Unknown Origin & Other Cancer Types |
Beckman Coulter Life Sciences received 510(k) clearance from the FDA to distribute its AQUIOS STEM System in the United States.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read MorePosted by Andy Lundin | Nov 13, 2023 | Leukemia |
A novel assay that identifies a unique molecular marker in acute myeloid leukemia patients may revolutionize how the disease is detected.
Read MorePosted by Andy Lundin | Nov 8, 2023 | Leukemia, Sequencing Systems |
Sequentify announced Stanford will be using the company’s NGS targeted panels for acute myeloid leukemia (AML) somatic mutation detection.
Read More